Additionally, the results of immunohistochemistry for IL‐1β and TNF‐α (Figure S8) suggest that EA may alleviate AD pathology by suppressing astrocyte or microglia‐related inflammation. This evidence concerns the gene IL1B and Alzheimer disease.